Ramucirumab in Squamous Non-Small Cell Lung Cancer
3 Views
administrator
07/14/23
The panelists, Benjamin Levy, MD; Edward S. Kim, MD, FACP; and Paul K. Paik, MD, assess clinical trial results of monoclonal antibody, ramucirumab, and its role in squamous non-small cell lung cancer.
-
Category
Show more
Facebook Comments
No comments found